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Summary of Discussion Sessions:
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by W. Victery,* H. A. Tyroler,t R. Volpe,f and L. D. Grant*
The International Symposium on Lead-Blood Pres-
sure Relationships was held in Chapel Hill, NC, April
27-29, 1987, with sponsorship from the Councils on
Hypertension and Epidemiology of the American
Heart Association; the Department of Epidemiology,
University of North Carolina; the International Lead
Zinc Research Organization; and the U.S. Environ-
mental Protection Agency. The program was struc-
tured so as to first present an overview of theories and
findings in the general area of human hypertension
and then to have speakers review the extant literature
on lead and blood pressure relationships, including
papers on the human observational studies of lead and
hypertension; related studies of lead and human
hypertension; occupational studies of lead and hyper-
tension; experimental studies of lead and hyper-
tension; and papers presenting related information
from work in progress. Invited discussants, invited
speakers, and other workshop participants were
encouraged to ask questions and to discuss needs for
future research. This report summarizes key ex-
changes of information during discussions after
individual papers were presented or during separate
discussion sessions. It also summarizes presentations
by several speakers who declined to publish in these
proceedings full-length papers on ongoing work.
In the first plenary session, the three speakers (H. A.
Tyroler, A. Chobanian, and C. Hennekens) gave over-
view presentations on the epidemiology of hyperten-
sion as a public health problem, mechanisms of hy-
pertension, and the impact of reducing high blood
pressure on more serious cardiovascular sequelae.
These talks oriented the audience and participants to
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the types of studies and methods of analysis necessary
to consider the possible influence of lead on blood pres-
sure and other cardiovascular effects and reviewed the
multiplicity of mechanisms that may influence the
measured outcome of a change in blood pressure. Only
limited discussion followed these introductory papers,
with resulting clarification of certain key points con-
cerning the relative role of various known or suspected
risk factors for hypertension and associated sequelae.
The next plenary session included a series of papers
that discussed human observational studies of lead
and hypertension, with special emphasis on addi-
tional analyses of National Health and Nutrition
Survey II (NHANES II) data and further analyses of
data from the British Regional Heart Survey. During
discussions following these presentations, aspects ofthe
NHANES analyses were clarified.
J. Schwartz (U.S. EPA) commented that he used
P. Gartside's (University of Cincinnati) regression
models with interaction terms for age and found none
of the interaction terms to be statistically significant.
Using somewhat larger age groups than Gartside did,
he found that lead was statistically significantly
associated with both systolic and diastolic pressure in
all 30 age groups. He questioned whether or not the
failure of Gartside to observe statistically significant
effects was due to small sample size subgroups. Gartside
doubted that the difference between the 20- and 30-year
age groupings was meaningful. He noted that it was
not infrequent for two individuals analyzing the
same data set to come up with totally different results.
Schwartz, although agreeing with this and noting its
relevance to Fort's findings (Schwartz obtained statis-
tically significant coefficients on regression analyses
for both systolic and diastolic pressure including all 64
geographic sites in his regression), pointed out that an
Expert Peer Review Panel convened by EPA, as well as
a review committee of the EPA Science Advisory Board
studying both his and the other NHANES analyses,
accepted the Schwartz version. Schwartz added thatVICTERYETAL.
inclusion of the 64 sites in his regression analyses
reduced the magnitude of the regression coefficients by
about 30%, notby the stated factor ofthree.
0. Carter (NCHS) questioned whether the Hispanic-
NHANES analysis was restricted to Mexican-
Americans. B. F. Fort (Ethyl Corporation) answered
in the affirmative, but pointed out that the analyses
presented to date were preliminary and that a corrected
data set was to be analyzed in the future. Carter pointed
out that the revisions involved only three persons and
that should not change the analyses. Carter empha-
sized that others using the Hispanic-NHANES data
should distinguish among Mexican-Americans,
Puerto Ricans, and Cuban-Americans. Carter noted
that acculturation, which may affect blood pressure
levels, and birth place should be explored for their rela-
tionships to lead and blood pressure. K. Mahaffey
(NIOSH) questioned whether there was a continua-
tion in the decline of blood lead levels in the Hispanic
NHANES. Schwartz responded that, although the
blood lead levels in Hispanic-NHANES were lower than
in NHANES II, one must acknowledge that there are
population differences. Any attempt to separate out the
Hispanics in NHANES II would be subject to the diffi-
culties of small sample sizes. S. J. Pocock (University of
London, UK) noted that the regression coefficient
which Fort obtained for the relationship of lead to
diastolic blood pressure was 1.96, a value quite similar
to the coefficient of 2.1 in the British data. He also noted
that when adjusting for site, the British coefficient
moved from zero to slightly positive. The NHANES
coefficients, when adjusted for site, were reduced to
values that were still positive but of smaller mag-
nitude.
There was a discussion regarding the reproduci-
bility of results based on analysis of the same data set.
Fort and Gartside reported that they were unable to
reproduce Schwartz's results, whereas the University
of North Carolina group obtained exactly the same
results as Schwartz, using precisely the same subjects,
variables, models, and analytic techniques.
P. Boscolo (University of Chieti, Italy) stated that
lead exposure is associated with cadmium and other
pollutant exposures and that interaction effects have to
be considered.
L. Grant (U.S. EPA) opened the general question
session by identifying several key issues: the signi-
ficance of adjustment for site, for geographical location,
analyses within different age groupings, and the
implications of any blood lead-blood pressure associ-
ations for major morbidity and mortality cardiovas-
cular outcomes, such as strokes orheart attacks.
D. Roxe (Northwestern University) inquired about
the measurement techniques used for lead and blood
pressure, whether subsets of the populations had had
recent acute exposure and what environmental sources
are considered the major sources of lead. Schwartz
reported that NHANES blood lead measurements were
taken in specially loaded vacutainers that were treated
to be trace element-free. Quality control indicated a
coefficient of variation of blood-lead levels of approx-
imately 15%, equivalent to a confidence interval of
approximately ± 2 ,ug/dL on the blood-lead determin-
ation. W. R. Harlan (University of Michigan) com-
mented that blood pressure in NHANES II was taken
on three occasions, seated at the beginning, supine
midway through, and a second seated blood pressure
near the end of the examination. Systolic pressure was
recorded as the initiation of Korotkoff sounds and
diastolic pressure as cessation of sounds (K-5). There
were a large number of observers, trained to record
blood pressure in a standard manner. Regarding
acute exposures to lead, the only historic information
was the 24-hr dietary recall. Those people who have had
a significant number of calories on the day prior to
examination were also the people reporting the highest
intakes of alcohol as their habitual consumption.
Schwartz remarked that the half-life of lead in the
blood was typically 30 days and that a single, higher-
than-average exposure dose is not going to have major
perturbing effects on adults' blood lead levels. Individ-
uals who work for lead exposure industries, as classi-
fied by NIOSH, were excluded from the sample. Exclu-
sion of these individuals resulted in a slightly higher
regression coefficient, which was still significant.
Pocock remarked that the methodology of blood lead
was more important than the methodology of obtain-
ing blood pressure in these studies. Blood lead was
measured under strict quality control methods at the
leading British laboratory. Blood pressure was
recorded on the London School of Hygiene zero-mud-
dler sphygmomanometer. There were three observers
per town. In addition to training to correct for observer
variation, observer differences were adjusted for in the
analyses. Pocock doubted that single exposures to
alcohol would have meaningful effects. It was his
opinion that food and water sources would be im-
portant causes of blood lead levels in the general popu-
lation, in addition to effects of heavy drinking and
smoking. Lead is still in British gasoline and is being
removed gradually and is lower than it was pre-
viously. This will influence the lead in dust, air, and
food. He was not aware of any occupational or ambient
environmental problems from lead smelters influenc-
ing his data. Schwartz commented that in the United
States there was a larger amount of lead in the general
population coming from gasoline than in England
and lower amounts coming from water. He estimated
that approximately half the lead in the general popu-
lation in the 1970s was based on gasoline as the pri-
mary exposure, accounting for higher levels in urban
areas.
M. Galvin (NIEHS) questioned the differences in
sample size between the Schwartz and DuPont
analyses. Schwartz responded that DuPont did not use
the same covariates that he did and that given some
missing covariate values there were resulting slightly
different sample sizes. Grant added that there are also
some differences in the subjects included or excluded.
R. Lilis (Mt. Sinai, NY) raised questions regarding
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the comparability of the British and American studies
on the distribution of the blood lead levels in the two
populations, the existence of a similar secular trend in
the United Kingdom and the United States, and
information regarding trends in blood pressure levels
in the United Kingdom compared to the United States.
Mahaffey inquired about hypertensives receiving
medication in the British studies, were they excluded,
at what level of blood pressure would medication be
prescribed, and regarding the distribution of blood
lead levels, what information is available regarding
quality control and intake of lead? Pocock thought
there might be a slight tendency to higher blood lead
levels in NHANES II but that in general the
distributions would be similar. Schwartz indicated
that the mean blood lead level in the NHANES
population was approximately 17 ,tg/dL. Pocock
indicated that it was 0.76 ,umole/L (equivalent to 13 or
14 gg/dL) in the British studies. The proportion of
individuals with values over 30 ,ug/dL was small,
suggesting generally similar ranges of blood lead in
the two studies. Pocock suggested that there are not
good epidemiologic data at present on trends in blood
lead levels in the British experience. Such data are
being assembled now and for monitoring over time
with the removal of lead from gasoline.
P. Elwood, Medical Research Council (MRC, UK)
has assembled several different approaches to this
question and he reported consistency among them of a
fall of about 4% per year over the last 10 years in blood
lead levels prior to reduction oflead in gasoline. Pocock
commented that there are not good data on trends in
blood pressure, but he suspected that there have not
been substantial trends. He added that hypertensive
medication is not as intensive in the U.K. as in the U.S.
Further, it was his opinion that treatment was not
initiated until relatively high levels of diastolic blood
pressure were observed. Elwood concurred that blood
pressure changes over time have been minimal and
that there is no good evidence either in trends in blood
pressure or antihypertensive treatment in Great Brit-
ain.
Lilis referred to data from Scotland relating levels of
lead in drinking water to blood lead, kidney function,
and hypertension, data which were not presented by
Pocock in his formal paper. Pocock responded that he
restricted his analyses to the blood lead-blood pressure
relationship. Lilis remarked that Pocock's data sug-
gested that the localities which had higher blood lead
levels were the areas ofsoft water and that the source of
lead, whether it comes from water, air, gasoline, or
other sources, is actually of secondary importance in
this discussion of the effect of lead on blood pressure.
Pocock concurred and justified his discussion of the
association of higher blood pressure with water soft-
ness in his presentation as of background descriptive
interest only. Pocock added that he included individ-
uals on hypertensive medication in his analyses since
their exclusion could lead to a bias due to their higher
than average blood pressure values. Fort commented
on studies of two towns in Massachusetts in which an
association was detected between sodium chloride
content ofthe water supply and blood pressure levels of
school children, controlling for other relevant
variables. He questioned whether there were other
variables depending on location, water supply, and
sodium chloride specifically, which could affect blood
pressure, and had not been controlled for in the data
sets under consideration.
D.-L. Zhu (University of North Carolina) inquired
about the relationship between erythrocyte protopor-
phyrin, body burden of lead, and blood pressure in the
NHANES cohort. Schwartz noted that erythrocyte pro-
toporphyrin did not correlate with blood pressure
levels in the NHANES studies. He indicated that in the
general adult population, erythrocyte protoporphyrin
is dominated by iron status and is a poor predictor of
lead status; this is in contrast to a child eating lead
paint chips who has marked elevation of blood lead and
marked elevation of protoporphyrin.
S. T. Weiss (Harvard Medical School) commented
on the implications of adjusting for site by pointing
out that site may in fact be a link in the causal chain of
the blood lead-blood pressure association, because site is
associated with water or air sources of lead and,
consequently, is the major determinant of blood lead. It
was his opinion that this distinction between whether
site is a confounder or a link in the causal chain could
not be resolved with cross-sectional data and that a
longitudinal study of changes in blood lead and blood
pressure was one potential way of resolving the issue.
A. J. Vander (University of Michigan Medical
School) questioned the relationship between decreases
in lead and the time necessary for an associated decline
in blood pressure, assuming that lead had contributed
to a rise in blood pressure. In particular, he inquired
about the effect on statistical associations ifover a 4-year
period when lead was decreasing, blood pressure did
not decrease. Schwartz responded that the question did
not relate to the observations, since controlling for all
other factors, blood pressure did change over time with
changes in blood lead. Vander was skeptical about the
time changes in blood pressure, but, assuming that
blood pressure actually did decline, did it do so for
reasons other than lead? Schwartz responded that
elaborate, detailed models, including control for many
potential confounders, failed to eliminate the blood
lead-blood pressure association. This included site-
and time-related variables.
W. Kannel (Boston University School of Medicine)
commented on blood pressure trends. It was his
opinion that there was no way to know whether blood
pressure actually changed in the general population.
There has been a massive amount of treatment intro-
duced over time, the indications for treatment have
changed over time as well, and currently, physicians
in the United States are treating people with lower
blood pressure. Under these circumstances, it is diffi-
cult to determine whether the prevalence of hyperten-
sion has changed over time. Harlan noted that com-
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parison of the distributions of blood pressure in
NHANES I and NHANES II, i.e., between the early and
the late 1970s, and suggested that the differences were
primarily at the upper end of the blood pressure dis-
tribution and suggested that treatment is one of the
major reasons for the decline and that there are only
small changes in mean values. Schwartz indicated
that this is one reason his group did analyses exclud-
ing people on hypertensive medication, although he
acknowledged that this approach results in truncating
the sample.
D. G. Beevers (University of Birmingham, Scot-
land) attempted to reconcile the apparent disparities
between the U.S. NHANES and the British Regional
Heart Studies. He suggested that participant selection
may have been partially responsible in that there was
oversampling of disadvantaged persons of relatively
lower social class in NHANES and unintentional se-
lection of higher social class individuals in the Re-
gional Heart Study. Pocock indicated that an attempt
was made to select a general practice that was represen-
tative of its community in each town in the British
Regional Survey. However, there was only a 78%
response rate of individuals coming in for screening.
He noted that the distribution of manual to nonman-
ual workers in the sample was generally similar to that
in Great Britain; however, there was a slight under-
representation of unskilled manual workers and a
slight overrepresentation ofthe professional classes.
Schwartz indicated that there was in fact an
oversampling of lower social status individuals in
NHANES, but this was done by design in advance and
sample weights were created, so that by weighing these
people less than others it was possible in a weighted
analysis to getback to a sample representative ofthe U.S.
population. Weights also were assigned to adjust for
nonparticipation in examinations, based on the fact
that 97% of the persons selected had demographic and
medical history information obtained from a home
interview.
Grant opened the question and discussion period of
the panelists. H. Smith (Statistical Consultant) queried
Pocock and Schwartz as to whether each had carried
out regression analyses within each site, which would
permit site-specific estimation of the blood lead-blood
pressure association controlling for the other major
covariates. Pocock indicated that his final model con-
tained adjustments for body mass, age, alcohol con-
sumption, social class, and smoking categories in
addition to 23 dummy variables to adjust for differ-
ences between towns. The number of individuals
within each site, approximately 300, were too few to
permit site-specific detailed analyses with multi-co-
variables. Schwartz responded that he could not do site-
specific regression analyses because for the 40 to 59year
olds there were 543 people in 64 sites, and the informa-
tion available per site would be markedly limited.
Smith inquired about separate analysis at each site
and then a meta-analysis of the derived coefficient
across all sites. Smith suggested this (which had not
been done) would be similar to the Landis approach,
which was a pooling using the Mantel-Haenszel
statistic across subgroups. Smith reiterated that what
he was interested in was the magnitude of the regres-
sion coefficient across the groups and not the signifi-
cance level. The magnitude of the estimated change in
blood pressure per unit change of blood lead was of
primary interest to see ifany association detected was of
importance. He stated that inference was the issue, not
the test of hypothesis. Further, he argued that the
selection criterion for admitting variables in a step-
wise procedure, which mandates establishing a sig-
nificance level to admit or discard a variable, is
something that ought to be avoided or used only with
caution. Schwartz responded by indicating that he
had adopted a model with variables generally agreed to
be associated with blood pressure, i.e., sex, age, body
mass, and race, and then, since blood pressure has been
hypothesized to be a multifactorial outcome, to have
included a large number of dietary, serum micro-
nutrient, demographic, and other factors which have
been found associated with blood pressure in some
studies. His approach was to see how stable the blood
lead coefficient was, including or excluding these
variables and under that circumstance using the step-
wise regression analysis approach. Schwartz empha-
sized that this approach was not used to establish a
model for blood pressure, but rather to test for the
stability ofthe blood lead-blood pressure relationship as
he expanded from the biologic model that included
universally accepted variables to models that included
variables that others have speculated about.
Smith queried R. Landis (University of Michigan)
regarding the rationale for adopting the procedures he
had used and which are discussed in detail in his
formal paper. His response was that the expected value
and variance in each subtable is computed conserva-
tively under a fixed margin assumption. It can be
viewed as a randomization model in which the beta
coefficient at each site can be estimated. Given the ex-
pected value and the variance for that component based
on the fixed margins of a conservative Fisher exact
kind of hypergeometric framework, you can see
whether or not the observed cross-product tends to
exceed its expected value on average across very small
subgroups of individuals. In the extreme, this would
be the matched pair design adjusting for all the co-
variates; although not done yet, it could be done and to
determine whether on average, the matched pair tends
to favor the elevated level of pressure being associated
with elevated level of lead. Landis prefers this to a
multiple-regression model with 63 site parameters.
Additionally, the procedure permits adjustment for the
role of 64 sites without incorporating the site effects
into the estimation of the partial beta coefficient. All the
statistical power is focused on estimating one beta coef-
ficient adjusted for all the other covariates. That beta
coefficient has a test statistic that is nearly identical to
the Mantel-Haenszel. In response to a question from
Grant, Smith responded that he had never seen the
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Mantel-Haenszel procedure applied this way before and
he was not certain whether the application was appro-
priate.
Kannel commented that it was necessary to return to
basic epidemiologic principles and to evaluate whether
or not a causal association is present. He set out the
following criteria: to determine whether the observed
relationship was found consistently, whether the asso-
ciation is strong, whether it is dose related, if it is bio-
logically plausible, whether it can be reproduced ex-
perimentally, and finally, if it is present when taking
confounding variables into account. Based on the
information presented, he believed the effect of lead on
blood pressure appears to be modest; however, within a
population context, given ubiquitous exposure, the
population attributable risk can be large, and this has
public health implications. However, he believes that
more information is needed. The shape of the dose-
response relationship of lead to blood pressure is not
clear. Is there an effect on blood pressure at toxic
exposures over the limit of 30 or 40 ,ug/dL? More in-
formation is required regarding mechanisms. Is the
effect short term or long term and cumulative? Kannel
noted that for hypertension in general, even for the
strongest of known population risk factors such as
obesity, mechanisms are unclear and so the absence of
this knowledge is not unique to lead. In assessing the
role of potential confounders, Kannel felt that, in place
of "mindless statistical numerology," it would be pref-
erable to have and test specific hypotheses as to how lead
might affect blood pressure in a population. Finally, he
noted that lack ofknowledge is no excuse for inaction, if
we know that there is a possible relationship and a
modifiable population environmental exposure. How-
ever, Kannel did feel that there is a need to establish the
nature of the association more precisely.
H. Dustan (University of Alabama) summarized
her reaction to the materials presented by stating that
she regarded the evidence as quite unclear whether
lead has an effect on blood pressure in large popula-
tions. She agreed with Kannel that it was difficult to
know which of the multitude of analyses with dif-
ferent results was correct.
The next plenary session was devoted to four related
studies of lead and hypertension. Following D. Krom-
hout's (State University of Lieden) presentation on the
Zutphen Community Study of elderly men, Boscolo
commented that the effects of lead exposure are very
different in young and old persons. He suggested that
the effects of lead exposure in younger individuals
would be mediated via mechanisms regulating blood
pressure through the brain and kidneys. Pocock
questioned whether Kromhout would have published
his findings had they not been statistically significant
(referring to the issue of publication bias). Kromhout
answered that he would have published the findings
regardless of the outcome, but would not have pub-
lished the blood lead-blood pressure results separately.
Lilis commented that removal of one outlier obser-
vation of an individual with high blood lead and
very high blood pressure resulted in the absence of a
significant relationship between blood lead and blood
pressure in Kromhout's presentation. Kromhout
responded that removal of the one outlier resulted on
univariate analysis in a borderline statistically sig-
nificant relationship between blood lead and systolic
blood pressure and absence of an association of blood
lead and diastolic pressure, but that the association no
longer was statistically significant upon adjustment
for body mass index and age.
Lilis further discussed the appropriateness of in-
cluding or excluding the outlier in the final analysis.
Smith commented that the decision rests upon the
range of inference to be made. If, in fact, the outlier is in
the range of inference, then obviously it has to remain
in the study. Alternatively, if the range of inference is
restricted to lower values, then it would be inappro-
priate to include it. Schwartz questioned the effect on
the magnitude of the regression coefficient including
and excluding the outlier. Kromhout responded that
there was only a small change in the magnitude of the
regression coefficient, but the p value became 0.06, i.e.,
no longer conventionally statistically significant.
W. Lee (University of Manchester, UK) raised the pos-
sibility of a threshold response of blood pressure to
blood lead levels. He interpreted the data presented as
showing very little effect of low blood levels on blood
pressure, suggesting a horizontal dose-response rela-
tionship with an upturn in blood pressure response at
some threshold value. Recognizing the limitations in
one observation, he suggested that perhaps the outlier
might indicate where the dose-response curve for the
blood lead-blood pressure relationship is beginning to
turn up.
Landis disagreed with Lee's interpretation of the
dose-response relationship. He interpreted the
NHANES data as showing an association of blood
pressure with blood lead down to levels of 5 ,ug/dL. He
suggested that, if anything, there is evidence that the
response of blood pressure may taper off at the higher
levels of lead. Landis commented that if there is a
threshold, it is for higher levels than those observed in
the NHANES data. Schwartz reported that he had tried
fitting a threshold model in the NHANES data and
had failed to find evidence of a threshold. He disagreed
with the characterization of an outlier in the Krom-
hout data, arguing that the single value does not
change the slope of the relationship much while being
influential with respect to the significance level, and
therefore it was not an outlier in the sense that there is
a different relationship at the observed level and at
lowerlevels.
After T. Moreau's (INSERM) presentation, H. Gonick
(Cedars Sinai, CA) requested some clarification of the
conclusions regarding lead's effect on red cell mem-
brane lead content and cation transport systems. If lead
binding to red blood cells affects Na+/K+ ATPase, one
would expect to see a positive correlation between the
two. Since that did not occur, one could reverse the
question and ask if the total blood lead or membrane-
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bound lead is a reflection of an active transport abnor-
mality characteristic of hypertension. Dustan also
queried Moreau concerning the lack of correlation
between membrane-bound lead and cotransport sys-
tems, in particular, how calcium may interact with
lead. Moreau indicated that his group was disap-
pointed in this particular finding, but there may be a
positive relation of membrane lead and K+ channels.
He suggested that the sulfhydryl groups of the Na/K
ATPase enzyme are probably reacting with lead, even
though the enzyme activity was not affected.
A. Johns (University of Miami) asked if inhibition
of this cotransport system could be responsible for the
increased contractility in smooth muscle cells of blood
vessels. Moreau replied in the affirmative. Johns said a
similar pump exists in uterine smooth muscles that
appears to be furosemide insensitive but it is still
responsive to agonists causing contraction.
Following the presentation of the paper by Weiss,
Schwartz questioned the findings over time and
whether or not a single measurement of blood lead lost
power as a predictor of blood lead levels in successive
years. Weiss responded that in the context of this
model, it was necessary to treat blood lead as a fixed
covariate, i.e., the assumption had to be made that blood
lead does not change over time. Landis asked whether
lead was analyzed as a continuous variable, rather
than categorically as intermediate and high. This was
of importance, since there was a large representation in
the upper levels, i.e., 22% of the men. Weiss indicated
that this had not been done; the data were simply
categorized at the start ofthe analysis.
Landis indicated that the Weiss study included a
large proportion who would be in the upper end of the
distribution of the general population, i.e., in NHANES
II. Kannel questioned the associations of alcohol intake
with blood pressure in the study and asked whether or
not Weiss was implying that the alcohol-blood pres-
sure association is entirely due to lead. Weiss re-
sponded that the distribution of reported alcohol con-
sumption in his sample was similar to that reported by
the average American. He suggested his findings may
reflect reporting bias. Regarding the association with
blood pressure, he pointed out that all men in the study
were normotensive and that the findings might result
from a relatively small study of limited power. He did
not believe any of his results vitiated any of the earlier
studies regarding the relationship of alcohol to
hypertension or alcohol to blood lead levels. It was just
that the alcohol association with blood pressure was not
demonstrable in his (small) cohort.
Gonick asked the first question about R. Wedeen's
(V. A. Medical Center, E. Orange, NJ) presentation; it
concerned whether the EDTA lead mobilization test or
the X-ray fluorescence bone lead measures of lead
burden had been correlated with any blood pressure
measurements. Wedeen responded that the limited
number of subjects did not make such analysis suit-
able. A follow-up question from Gonick asked the rela-
tionship of these two measures of lead to that in the
postulated target tissue for hypertensive effects, e.g.,
vascular tissue. Wedeen did not feel this was likely to be
the target tissue. He plans to examine platelets and their
calcium metabolism further, as well as endothelial
repair. Moreover, lead concentrations may not be per-
ceptibly higher in any target tissue. Gonick asked
Wedeen to consider as toxic, the lead in the ionized
form circulating in extracellular fluid, platelets or
vascular tissue. Wedeen agreed that lead in bone
(while being the best measure of past exposures) was
unlikely to be indicative of damage to the bones;
however, it is available for exchange with extracellular
fluid and consequently to other tissues.
P. Grandjean (Odense University, Denmark)
brought up various concerns about the use of X-ray
fluorescence for lead burden measurements; the tech-
nique involves use of X-rays, it is expensive, and the
measurement obtained varies with bone type. In
addition, in renal failure dialysis patients, the serum
level of aluminum is elevated. Aluminum binds to
and affects bone hydroxyapatite, especially its ability to
respond to homeostasis of serum calcium by para-
thyroid hormone. Therefore, bone metabolism of lead
may be considerably altered in those patients with
concomitant bone disease. Wedeen (in collaboration
with scientists in the Netherlands) has histomor-
phometric evidence that the amount of lead in bones of
renal disease is not altered.
Dustan queried if there is a difference between races
with regard to renal disease. According to Wedeen,
blacks are overrepresented in dialysis units; in spite of
small numbers, he found these blacks had higher lead
levels. Unfortunately, in clinical research, the number
of patients studied is necessarily limited.
Vander asked for clarification on the ability of the
X-ray fluorescence method to detect low level lead expo-
sure. Dr. Wedeen indicated at present that detection
limits are approximately 10 ppm with an error of 10 to
20%. Values in the general population are expected to be
6 ppm; therefore, the technique may be useful in
selecting high risk groups. Vander was actually more
concerned about the lack of correlation in the bone lead
content with respect to the constant amount of lead
measured in the EDTA mobilization test. Wedeen
stated that the total number of patients has been rather
limited when compared to the numbers in epidem-
iologic studies.
The next plenary session consisted of three presen-
tations on persons who were occupationally exposed to
lead.
Following the presentation of W. C. Cooper (phy-
sician-consultant) on his lead mortality study, there
was a question from P. Pontzer (Federated Fry Metals
Company) as to whether Cooper had attempted to
correct for incompleteness of data on the death certifi-
cates used in the study. Cooper responded in the nega-
tive because he felt that the same correction could not be
done for the comparison groups. Kannel then ques-
tioned why lead battery workers were separated from
smelter workers, since he felt that if you combined the
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data oflead-exposed workers and compared these data to
the general population, a level of statistical significance
would be achieved for some of the outcomes. Cooper
indicated that he had carried out such an analysis, but
it did not alter the results enough to be justified.
Furthermore, these two groups of workers are in dif-
ferent plant operations and thus have different pos-
sibilities for confounding exposures which are
important for assessing relationships with various
types of cancer, specifically lung cancer and stomach
cancer. Cooper suggested that if the age distributions
and different hire distributions of these populations
were examined, one would feel more comfortable see-
ing these two groups separated.
J. Bosch (George Washington University) asked
whether there was any knowledge of workers that
developed chronic renal failure and then died, to
which Cooper indicated that he did not know about
such cases. Lilis suggested to Cooper that since higher
exposure levels were found in the smelters as compared
to the battery plants and higher mortality rates for
chronic renal disease were seen in the smelters, this
would indicate that there is a dose-response relation-
ship. Cooper responded that the data appeared con-
sistent with that hypothesis.
Smith then asked what the total population of
workers available to exposure was in the smelter and
battery plants and their person-years experience.
Cooper stated that battery plants had roughly 100,000
person-years and the smelters had 50,000 person-years.
After S. Selevan's (U.S. EPA) paper, Gonick asked a
question concerning Selevan's designation of high
lead vs. high lead/low other for exposure levels in her
study. Gonick felt that the high lead/low other
designation might be different for chronic nephritis
than for cancer. For example, arsenic does not have an
adverse effect on kidney function, but is presumably
carcinogenic. On the other hand, silicon, copper,
cadmium, and perhaps gold and silver do have an
adverse affect on the kidney. Gonick suggested that a
regrouping of the high lead/low other classification
looking specifically for the silicon and cadmium effects
on chronic nephritis might give a somewhat different
insight to the current groupings in the study. Selevan
responded that there would only be fairly minor
differences, since the expected and observed were so low.
Selevan suggested that NIOSH take a look at Gonick's
suggestion.
R. Goyer (University of W. Ontario, Canada) then
questioned whether the use of autopsy material, as well
as information from death certificates, might give a
better view of the nature of the renal disease and
possibly the incidence of renal tumors in the study
population. Selevan agreed and indicated that NIOSH
had recently collected some pathology reports for such a
purpose. Dustan then noted that there was no increase
in hypertension-related deaths, but wondered whether
there was an increase in hypertension in the overall
cohort. Selevan indicated that there was no informa-
tion on this because the mortality study only included
those things which find their way to the death cer-
tificate. Dustan suggested that this information might
be found through annual physical examination
records. Selevan stated that this was not necessarily so
since there was not a lot of information on blood leads
in the older medical records and since annual physical
exams were not carried out at the plant.
H. A. Tyroler (University of North Carolina) then
asked whether Selevan examined multiple cause
coding and whether or not in proportionate mortality
terms or in relationship to high exposures, there were
more instances of hypertension and hypertension-
related conditions as secondary causes ofdeath. Selevan
indicated that a secondary analysis was not done except
for silicosis. Tyroler suggested it might be informative
to do a secondary analysis.
Boscolo noted that Selevan's cohort consisted of a
peculiar population ofworkers exposed not only to lead,
but also to cadmium, arsenic, copper, and other
elements, not only at work, but at home. He felt it would
be difficult, therefore, to compare the data of this study
to other data on people exposed only to lead. Selevan
agreed with this observation, remarking that it was
difficult to know what type of interactive effects may be
occurring and what effects may be caused by other
kinds of exposures. It is extremely hard to determine
definite conclusions from this type of work.
Following W. L. A. M. de Kort's (Ministry of Social
Affairs and Employment, the Netherlands) paper,
Dustan noted that an increase in the average arterial
pressures for both systolic and diastolic blood pressures
was observed. Also, among the lead workers as opposed
to the controls, there was a bit of an age difference
between the two groups with the workers being a little
older than the controls. Dustan noted that this age
difference becomes very important in regard to blood
pressures. Dustan then asked whetherthere were people
with real hypertension, people with diastolic pressures
greater than 105, or was this just part of the aging
process. de Kort responded that mixed pair analyses
had been done and consistently a difference in systolic
blood pressure was found. The diastolic blood pressure
was not statistically significant in the mixed pairs
analyses.
de Kort noted that there were problems in obtaining
exposure levels at the plant. There was an indication
that the time-weighted averages appeared lower than
the threshold limit value, which was 105 ,ug/m3 at the
time, but peak values often exceeded 10-fold this
threshold limit value.
Lilis stated that she thought that not adjusting for
body mass in a hypertension study was such a draw-
back that one could not possibly draw any conclusions.
de Kort disagreed with this, stating that he had not
seen studies where body mass index and blood leads
were highly correlated, and, furthermore, if body mass
index had been included, there would have been a risk
of overmatching in such a small group which would
be very serious. de Kort then noted in response to
another question by Smith that the time frame of his
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data collection was one month.
Lee noted from listening to all papers presented so far
at the conference that there appeared to be a very slight
rise of blood pressure over a range of blood leads,
something like a 2-mm Hg/10 ,ug Pb/dL blood. Yet, in
the first two mortality papers, there were observations
of people dying from renal disease and perhaps hyper-
tensive disease, from some rather ill-defined but
generally accepted very high blood lead levels. Lee sug-
gested that perhaps something was occurring at
higher levels of exposure or that lead was having an
effect in higher doses and producing renal disease
without producing marked hypertension. de Kort
responded that when people are exposed to high lead
levels, effects will show up that will not necessarily
show up at lower levels. Also, de Kort stated that he
disagreed with the theory put forth by Wedeen that the
kidney is of importance in the hypertension rela-
tionship. He believes it is the vascular wall that is
important. However, if one is exposed to insoluble lead
components, most of the material remains in the
lungs. So, perhaps the lung is the target organ where
the angiotensin converting enzyme plays a role in
generating vasoactive agents.
Schwartz remarked that he was disturbed by
hearing people talking about very small effects and
called the audience's attention back to the original
comments made at the beginning of Monday's session
on attributable versus relative risk. He stated that he
did not believe that anybody who has done work on
lead and blood pressure thinks that lead is the principal
determinant of blood pressure. Furthermore, everyone
agrees that the slope of the relationship with body mass
is much bigger and more stable than blood lead. The
problem is that it is very difficult to change people's
body mass index. It is even more difficult to change
their age, and that goes in one direction as far as we
can tell. In terms of a slope of 2 mm for a 10 gg/dL
change in blood lead, Schwartz felt that that was
roughly in the ballpark of the results that he found in
his study and that Pocock found in his study. To put
that into perspective, Schwartz noted that there had
been almost a 10 ig/dL change in the average blood
lead level of American adult males since the mid-1970s.
If, in fact, 10 gg lowered the average systolic blood
pressure in the United States by 2 mm Hg, then
everything we have seen from prospective cardiovas-
cular disease studies suggests that while it would not
produce dramatic changes in the relative risk of the
largest cause of death in the United States, it might
have some important public health consequences,
which is the real issue here.
Tyroler then expanded on Schwartz's point by
stating that there had been a mean difference of only
about 5 mm of diastolic Hg between the treated and the
control group in the Hypertension and Detection Fol-
low-up Program (HDFP). That was attended by almost
a 20% reduction in all-cause mortality among middle-
aged adults and so a seemingly small mean difference,
2 mm Hg, at the population level would be associated
with as much as an 8 to 10% decrease in all-cause mor-
tality. It is not trivial in terms of its public health im-
pact. Schwartz then remarked that a relative risk of
1.08, while important for public health consequences, is
rather hard to find in studies looking at specific mor-
tality ratios.
Vander noted that there appeared to be some
unanimity. He agreed with Lee that there may very
wellbe a difference in the dose responseforrenal disease
and for hypertension in experimental animals. Most
of the published work on experimental animals shows
certain doses of lead will produce high blood pressure
and as one goes higher, the high blood pressure
vanishes. Given the difficulty of doing epidemiology
studies, Vander felt that what he had heard so far was
in pretty good agreement. In fact, Vander felt that there
was a remarkable agreement in terms of the expected
rise in blood pressure that would occur for a given rise
in blood lead. If one uses those doubling doses, the
value that one comes up with from lowering blood lead
from 16 down to 4, and 4 is still quite a high number
for preindustrialized societies, is in the ballpark of 5
mm Hg. That is a very large reduction in blood pres-
sure for the general population. In terms of what was
heard on Monday, Vander noted that approximately
40% ofpeople would go from being labeled hypertensive
to being labeled normotensive. He felt that these very
small changes in blood pressure are extraordinarily
important.
J. Rosen (Albert Einstein Medical School, NY) then
clarified some statements concerning the K X-ray
fluorescence instrumentation that Wedeen spoke
about. He noted that his instrumentation at Brook-
haven, at Einstein, and at Montefiore Medical Center
was completely different from the instrumentation
used by Wedeen in East Orange, NJ. Rosen's instru-
mentation, which is based upon soft L X-rays of lead,
has a minimum detection limit of 2 ppm. It also has
the capability of exposing children as well as pregnant
women to virtually no radiation other than what one
would anticipate on a trip to Denver, CO. Rosen
believes his instrumentation is widely applicable to the
general U.S. population and noted that he would be
presenting his data on 66 children using L X-ray
fluorescence at an open meeting following the con-
ference.
The panel of invited discussants then gave their
views on the session. Kannel made some general
comments on the occupational epidemiology studies.
He felt the studies seemed to rely heavily on death
certificate evidence of outcome and that these can be
imprecise, particularly in respect to the hypertension
end point depending upon whether one uses multiple
cause certification, underlying cause of death, or stated
causes of death. Kannel also felt that the studies relied
upon external controls, or comparisons; that is, stan-
dardized mortality ratios which he felt rather uneasy
about. He also noted that the healthy worker effect can
often appear in epidemiologic studies because
investigators often use the general population expe-
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rience as an external control. There is also a lack of
adjustment or information on major confounding
variables such as relative weight, alcohol intake,
cigarette smoking, and factors related either to lead or
to hypertension. Kannel felt there was an imprecise
measurement of the actual exposure to lead in these
studies. There are arbitrary decisions as to where cut
points are made when the exact dose-response rela-
tionship is poorly defined. There also seems to be low
power to detect some ofthe excess mortality for some of
the uncommon causes which are being sought after
making it very difficult to draw conclusions about the
relationships. When one finds an excess of perhaps 30
to 40% which is significant, the significance test
merely tells you that you cannot place much confi-
dence in your estimate. It is always troublesome to find
a major excess that would be significant from a public
health standpoint, but not be able to say whether your
estimate is precise enough to judge whether it is true.
Smith felt that one should be careful about saying
that the papers presented were moving in the same
direction. He noted C. Henneken's (Harvard Medical
School) paper on the combination of clinical trials that
pointed out very clearly the difficulty of combining
information from across a wide variety of experi-
ments. Henneken threw out half of the trials and ended
up with a very small set because the investigators did
not adhere to strict protocol and strict collection of
information. One must, therefore, be very careful with
a combinational type of inference when comparing
groups of studies.
Dustan then gave her comments. She stated that the
evidence presented so far suggested that there is a
relationship between blood lead or lead exposure and
blood pressure. She noted that there was no informa-
tion about the mechanism of this relationship; the
relationship seemed to be of relatively low power, but
could be significant. Dustan asked whether there is an
experimental model for the effect of chronic lead
intoxication on blood pressure, and if such a model
exists, whether that model is different than acute
intoxication. If it is not different in terms of its
determinant, then Dustan suggested using acute
intoxication for a further study. Dustan remarked
that this is one of the major issues that needs to be
addressed because it is the influence oflead on the blood
pressure ofthe population that seems to be so subtle and
that is very difficult to determine. Dustan noted
another confounding factor. As we reduce the lead in
the environment through the reduction of lead in
gasoline, are we then going to see an important
decrease in the mean blood pressure of the population.
Dustan felt that if it does happen, it would be nice to
know what the decrease is due to and questioned
whether we would ever know what it is due to. Dustan
suggested that in the discussions that followed later in
the morning and afternoon perhaps one would get
some idea as to whether there are experimental models
of chronic lead intoxication that suggest lead having a
role in producing hypertension.
Investigators who have performed research in ex-
perimental settings on the effects of lead on the cardio-
vascular system spoke at the subsequent session.
W. Victery (U.S. EPA) presented a short overview of
chronic exposure protocols, using both high and low
exposure levels, which were evaluated for blood pres-
sure effects. Vander reviewed findings ofa lead effect on
the renin angiotensin system, and R. Webb (Uni-
versity of Michigan) discussed the effects of lead expo-
sure on vascular reactivity. These talks were followed
by S. Kopp's (Chicago College ofOsteopathic Medicine)
findings on cardiotoxic effects of lead; the final pres-
entation by Boscolo was on neurohumoral effects of
lead exposure.
Following the presentation of Kopp on cardiotoxic
effects oflead, there was a question from de Kort on the
effect of anesthetics on the blood pr'essure and cardiac
effects observed in the experimental animals. Kopp
indicated that they no longer use pentobarbital because
it tends to blunt the measured effects of lead or
cadmium on the cardiovascular system but have
found that a mixture of Ketamine and Xylozine are
effective. In addition, pentobarbital depresses the car-
diovascular system responses of lead-exposed animals
more than those of control animals so that the dif-
ferences seen between the groups is an underestimate
rather than an overestimate.
There was a question directed to the speakers regard-
ing any evidence that the high renin levels observed
in the lead-exposed animals were related to sodium or
fluid imbalance. Vander responded by indicating that
in other published reports from the Michigan group,
animals with similar lead exposure had a subtle defect
in sodium reabsorption by the kidney. The animals
initially responded to a sodium-restricted diet by
excreting more sodium than control animals. There
were no differences in steady-state sodium balance.
Whether this finding was correlated to the renin level
was not determined, e.g., by using blocking drugs for
the renin angiotensin system to determine the causal
role of renin.
Lilis asked for clarification regarding Boscolo's
remarks about a possible genetic component to
susceptibility to blood pressure changes related to lead
exposure. The two agreed that this hypothesis would
require further study. Wedeen indicated that humans
with essential hypertension may have excess body
burdens of lead that are not remedied by chelation
therapy. On the other hand, patients with elevated
blood pressure during an acute lead poisoning
respond to chelation therapy by reduction in blood
pressure. Vander pointed out that there is no experi-
mental evidence that removal of lead from the animals
will lower blood pressure. There were additional com-
ments by the speakers who indicated that we should
recognize that the data are quite different when
animals are exposed to chronic low levels of lead com-
pared to acute effects ofhigher level lead exposure. This
appears to be the case in animal experiments but is
probably also the case in the two types of human expo-
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sure. Kopp explained that the cardiac effects seen with
acute versus chronic exposure are clearly different
(with acute or high-level chronic exposure being car-
diodepressive while low level exposure produces
enhanced contractility).
The two invited discussants, Goyer and Johns,
wrapped up the session. Goyer, a pathologist well
known for his studies of ultrastructural and chemical
changes in metal nephrotoxicity, indicated that from
his viewpoint, blood lead levels resulting from lower
doses of lead will not be reflected in renal lead con-
centration in rats of more than 2 to 3 ,ug/g. Patho-
logical changes in the kidney are usually not
observable until the renal concentration exceeds 10 to
15 ,ug/g. At the high levels of exposure, there are
measurable changes in intracellular calcium that are
so severe that the cells are unable to perform their
functions. At this point, he would not expect to see any
physiological response to pressor amines, changes in
renin levels, or other regulatory systems. These levels of
lead exposure are quite different from the exposure
levels seen in the general population. For experimental
studies, documentation of the range of blood lead
associated with the range ofobserved blood pressures is
needed. Finally, Goyer urged that researchers consider
the essential metal content of the dietary regimen
administered with the lead dose because the toxicity of
a specific lead dose can vary 20-fold by reducing
calcium content in the diet. Similar effects can be
obtained by altering iron or zinc levels. Several other
scientists indicated that the relative inconsistency
between administered dose and blood lead level
achieved should be considered when considering the
effect or lack thereof on blood pressure. In addition,
because the rat kidney accumulates much more lead
for a particular blood level than do human kidneys, we
need to determine lead concentration of other critical
target organs (including vascular smooth and cardiac
muscle, and juxtaglomerular cells) in order to deter-
mine which responds in parallel with blood lead.
Johns proposed a number of critical experiments to
understand how lead may be affecting blood pressure
and whether blood pressure changes can be reversed by
removing lead from the diet. Inhibitors of angio-
tensin converting enzyme should be tried to deter-
mine if this prevents the pressure increase during lead
exposure. Levels of intracellular calcium should be
measured and calcium or potassium channel blockers
might reduce the effects oflead.
The discussion of the last few minutes of this session
delved into why some experimental differences in
blood pressure were so much greater than seen by other
investigators (for example, the 50 mm Hg increase seen
by the Italian scientists). Are we actually dealing with a
model that is analogous to the human situation, or do
we need to determine an animal model that demon-
strates only a few millimeters of mercury increase in
blood pressure which is attributable to lead exposure?
There were two sessions devoted to mostly unpub-
lished studies. Some of these are to be found elsewhere
in this volume; the main findings coming from the
other studies will be summarized here for sake of
completeness.
H. Perry (Washington University School of Medi-
cine, St. Louis) presented new findings on low-level
lead exposure in experimental animals. He noted that
in a pilot experiment they found that if lead exposure
was terminated for 2 months after a 6-month exposure,
the 0.1 ppm lead-exposed rats became normotensive
while the 5 ppm did not, and 1 ppm were between the
two. In response to a question from Goyer, Perry gave
the specific trace mineral components of the rat chow
used. Several audience members tried to evaluate these
lead doses with respect to that seen in the human
population. A calculation made by Wedeen illustrated
the total amount the rat ingests is of the same order as
the human body burden over a lifetime. Vander
pointed out that the true lead burden in the rat is
much lower because of the lower gastrointestinal
absorption rate of lead in rats compared to humans.
de Kort pointed out that when anesthetics are used to
obtain blood pressures in animals, there may be an
effect of lead on the effect of the anesthetic on blood
pressure. Perry agreed and indicated that animals are
currently studied without anesthetic (which results
in higher control blood pressure measurements), but
the levels seen in the metal-exposed animals are un-
changed. In addition, there is more consistency in the
readings and lower standard deviations.
In the discussion following Gonick's talk, it was
noted that accurate and sensitive methods for mea-
suring plasma lead as the important biological
indicator oflead exposure are not available as yet.
C. Morris (Oregon Health Sciences Center) in-
formed the audience about the findings in a clinical
trial with calcium supplementation in patients who
had their blood lead and erythrocyte protoporphyrin
(EPP) measured and blood pressure monitored. They
found that, in spite of modest blood lead levels, there
was a positive correlation between blood lead, EPP, and
diastolic blood pressure. In addition, they believe that
the blood pressure response that occurs with calcium
supplementation is probably independent of changes
in blood lead concentration.
F. Hodgson (University of Pittsburgh) presented the
paper originally expected to be given by Parkinson.
Cross-sectional data from approximately 250 occupa-
tionally exposed U.S. workers and 170 controls were
reanalyzed to examine the contribution of current,
recent, and cumulative indicators of lead exposure to
systolic and diastolic pressure. Only TWA (time-
weighted average) lead exposure (which was collinear
with age) was statistically significantly correlated
with both systolic and diastolic blood pressure. None of
the indices of lead exposure accounted for more than
2% of the variance. This regression coefficient is fairly
similar to that derived in the NHANES data.
Schwartz queried Elwood regarding the blood
pressure data from the Caerphilly Study in that the
values were higher than those obtained in the rest of
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Wales. Elwood noted that the data from the Welsh
Heart Program are standardized to age 40, while the
Caerphilly men had a mean age of 54. Their blood
pressure values are appropriate forthe age differences.
Grandjean reported on a study of blood lead-blood
pressure relationships with alcohol consumption and
hemoglobin values as confounders. The population
studied was approximately 1000 men and women born
in 1936 in 3.5 municipalities west of Copenhagen,
Denmark, who were presumed to be representative of
the entire country of Denmark. Blood lead was
significantly associated with both systolic and
diastolic pressures with a doubling of blood lead
associated with an increase in blood pressure of 2 to 3
mm Hg. Among several predictors, only blood hemo-
globin and alcohol intake were true confounders.
When taken into consideration in the regression
analysis, all statistical significance was lost. There was
also an association of blood lead with smoking;
smoking is also an important risk factor for increased
blood pressure.
Kannel questioned the finding of a positive rela-
tionship between blood pressure and cigarette smok-
ing, whereas most epidemiologic studies show an in-
verse relationship, i.e., those who smoke have some-
what lower blood pressures which may be attributable
to lower relative weights among smokers.
Grandjean responded to Kannel's question by indi-
cating that smoking was treated as a discrete variable,
categorized into five different groups and that smokers
who smoke between 15 and 24 cigarettes per day actu-
ally had a lower blood pressure than did nonsmokers.
Dustan questioned Grandjean's interpretation of the
hemoglobin, blood lead-blood pressure association and
questioned whether or not it was not possible that the
causal chain was in the opposite direction, i.e., hyper-
tensives tend to have lower blood plasma volumes and
subsequently can have increased hematocrits. In that
circumstance, the hemoglobin and hematocrit would
be the explanation for the increased blood lead.
Grandjean accepted that interpretation.
Schwartz confirmed Kannel's observation and
noted that there was a negative association between
smoking and blood pressure in the NHANES II and
that was present controlling for both body mass index
and body fat. Smith questioned the nature of the uni-
variate association between smoking and blood
pressure prior to adjusting. Schwartz could not recall
the association in the NHANES data. Kannel noted that
it was negative in Framingham, i.e., that the negative
univariate association was changed to a positive one
after addition of the control variables. Schwartz also
reported that in NHANES the hemoglobin did not
seem to be responsible for the blood lead-blood pressure
association, as stratifying by hemoglobin levels did
not change the regression coefficient of blood pressure
on blood lead. Grandjean indicated that the association
with smoking was complex in his study and blood
pressure was higher among those who smoke between
1 and 14 g oftobacco/day, whereas it was lower in those
who smoke 15 to 24g.
Kromhout inquired about the association between
change in blood lead and change in blood pressure.
Grandjean did not have those data in a form available
for presentation. Pocock requested information re-
garding regression coefficients rather than signifi-
cance levels. Grandjean responded that the coefficients
which approached statistical significance were positive
and those that were not statistically significant were
both positive and negative but very close to zero.
Pocock questioned the evidence regarding alcohol
consumption having an acute metabolic effect.
Grandjean responded that this is based on an experi-
mental study performed in Yugoslavia wherein a few
"shots of ethanol" resulted in an increased blood lead
level after a few hours. Thus, even if participants had
had a 13-hr fast, there could be a residual metabolic
effect of alcohol. Pocock questioned the statement that
there is no lead in cigarettes and pointed out that he
found relationships that persisted even after adjust-
ment for alcohol consumption. Grandjean reported
that studies of liver enzymes suggested under-
reporting of alcohol consumption, particularly in
women in whom the correlation of smoking with
blood lead persists after adjusting for alcohol intake, i.e.,
that there probably was underreporting of alcohol
intake. Pocock continued questioning regarding the
change in lead content of cigarettes in recent years.
Grandjean reported that there was definitely a very
high lead content 30 or 40 years ago; at the time, lead
arsenate was used for spraying tobacco fields, a practice
not followed any longer. Recent analyses have indi-
cated there is much less lead in tobacco at present. Lilis
commented on the exquisite control for age in
Grandjean's study, which might be too narrow to be
able to comprehensively assess any relationship be-
tween blood lead and hypertension. She requested more
detail regarding the distribution of blood lead levels
and systolic and diastolic blood pressure in Grand-
jean's study to permit comparison with other cohorts.
Following the presentation by L. Neri (University of
Ottawa, Canada), there was some discussion about the
fact that the values for some blood lead measurements
were so low that no parameter value was obtained. The
authors tried several different methods to correct for
these in the overall regression analysis.
Beevers described studies performed in the city of
Birmingham, an industrial city with workers occu-
pationally exposed to lead. In 1976, Beevers published a
report on these workers in which only a weak
association between blood lead and blood pressure was
found. In a new study, additional analyses and clin-
ical measures have been obtained on approximately
700 lead workers. No excess prevalence ofhypertension
was found in the lead workers. Workers with mean
blood lead values of 33.6 ,ug/dL show a weak (r = 0.09),
but statistically significant (p < 0.01), association
between blood lead and blood pressure; this trend
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remained significant after analysis of covariance
which took into account age, body mass index, and
duration of lead exposure. No convincing relationship
was found between blood lead and alcohol intake, but
cigarette smokers did have higher blood lead levels
than nonsmokers. There was no correlation between
systolic or diastolic blood pressure and zinc proto-
porphyrin levels. In the comment period after this
presentation, Boscolo indicated that it was very im-
portant to recognize that these workers were carefully
monitored by their employer and that this was not
always the case in factory settings. Hodgson reminded
Beevers that in his original publication it appeared
there might be a different (even negative) correlation
between blood lead at high levels and blood pressure.
Regression coefficients determined by dividing the
blood lead range into four segments appeared to be
different. Beevers had not done this in the present
study but thought it would be helpful in additional
analysis. Rosen asked if there appeared to be a relation-
ship between blood pressure and length of exposure but
Beevers said that they had not found this to be the case.
The following discussion took place after D. Sharp's
(University of California at Berkeley) presentation.
Sharp questioned the inclusion of cigarette smoking
in regression analyses if it is not related to blood pres-
sure. Smoking can act as a vehicle for lead exposure.
Similarly, even though there is some evidence that
alcohol intake is related to increased blood pressure,
there is even better evidence that alcohol can act as a
vehicle for lead exposure. This may bias the blood lead-
blood pressure relationship toward zero by overcon-
trolling for lead exposure. Pocock responded that this
has been an area of controversy and had it been
excluded, he might have been accused of missing an
important factor. Weiss indicated that, for a variable to
be a confounder, it has to be associated both with the
exposure and causally with the outcome variable.
Pocock felt that the definition of a confounder and
criteria of an appropriate covariate for inclusion in the
model were two different things. He noted that among
most of the studies presented there was a weak associa-
tion between both smoking and alcohol and blood
pressure. Since the blood lead-blood pressure associa-
tion is weak and because the association of the covari-
ates and the outcome variables vary among different
data sets and are themselves weak, this might be one of
the reasons why different results were being seen in
different studies.
Kannel noted that causal inference is the issue. He
cited the analogy of overweight in relation to coronary
disease, which disappeared as a risk factor when one
took into account variables such as blood pressure,
glucose, cholesterol, and uric acid. This, however,
merely indicated links in the causal chain; as weight
increased, the intervening variables left no variation
to be explained by weight. He pointed out the necessity
to keep the processes in mind when drawing causal
inferences.
Smith pointed out that the difficulty in inter-
pretation relates to the research design. In the ideal
model, one could determine the causal effects inde-
pendent of each other. The difficulties with the experi-
mental research relate to two factors; one, absence of
hypotheses regarding the causal models and, second,
in demographic survey research there is no unique
model.
Carter reported experiments in rats that indicated
that rats with very high blood lead levels were the ones
that ingested more alcohol and cautioned against the
interpretation of cross-sectional associations of blood
lead and alcohol consumption in terms of the causal
direction.
Schwartz declined to comment on whether people
with higher blood lead values drink more or not. He
commented that studies in humans show variability
in the association of alcohol consumption with blood
pressure. Similarly, there was variation among the
studies between the relationship ofblood lead and blood
pressure. If alcohol is a source of lead, then the obser-
vational studies will be unable to distinguish the
independent causal contribution of lead and alcohol to
blood pressure. Pocock said that he did not see this as a
major problem because alcohol remains a relatively
minor source of lead. He noted that there are num-
erous individuals who are either nondrinkers or
fairly light drinkers who still have measurable lead
levels and that it was possible to treat these two as
separable statistically and etiologically.
Grandjean indicated that in his population a
reported intake of two "shots" of alcohol per day was
associated with an increase of blood lead by about 1
gg/dL, which was not insignificant. In the presence of
a weak association, adjustment for alcohol may
eliminate a blood lead-blood pressure association. He
suggested, in prospective studies, that the cohorts be
restricted to individuals who ingest just a certain
amount of alcohol per day and can then be followed
over time, i.e., for example, being measured when
hired and then later as exposed lead workers. Ware
pointed out that the animal experimental work
indicated no influence of alcohol on absorption of lead
and that, in his opinion, the question was how much
lead there is in the alcoholic beverage. He suggested
that this varies among studies performed in different
countries and that he did not believe that this was a
significant question in this country.
M. Velasquez (George Washington University,
Washington, DC) questioned whether anyone had
studied the blood lead levels among a population of
essential hypertensives and whether these were
different from the normal population. Further, he
questioned Kannel about the association of body mass
index to blood pressure in the hypertensive range.
Kannel responded that the regression between blood
pressure and weight appeared fairly linear, that the
regression between weight gain and change in blood
pressure also appears to be quite linear and extends into
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the hypertensive range. Kannel disagreed with
Velasquez's interpretation of a flattening of the blood
pressure, body mass index relationship for blood
pressures above 150 systolic or 90 diastolic mm Hg.
Smith cited the use of standardized regression
coefficients in the social science literature and ques-
tioned whether or not conversion of the NHANES data
to that form might be a way of comparing association
across studies and also within studies when control-
ling for other variables. There was no response to this
suggestion. Gonick advanced an additional possible
mechanism regarding alcohol. The diuresis associated
with alcohol consumption could lead to hemocon-
centration, increase the hemoglobin and therefore
secondarily increase the measured total blood lead. He
suggested that analyses should control for hemoglobin
levels.
Tyroler introduced the final session of the
symposium and stated that it was planned to provide a
synthesis and overview of the material presented at the
symposium. The objectives of the symposium were to
have the principal investigators review their pub-
lished research and to have open discussions among
them and the audience, and to present all identified
ongoing relevant research that had not yet been
published. An assembled panel of discussants were to
synthesize the observational epidemiologic, clinical,
and animal experimental materials. Questions that
were to be considered included the following: What do
we think the assembled information means? Is there
an association between blood pressure and blood lead
levels in epidemiologic studies? If there is, what is its
strength and does it vary among subpopulations?
Combined with the clinical and experimental obser-
vations, do we believe that there is an association
which persists after controlling for potential con-
founders? Do we believe that it is causal? Insofar as
those questions can not be answered definitively, ad-
ditional research needs are to be identified.
The summary that follows highlights the discus-
sions in the order of their presentation. Considerable
editing has been introduced; however, every effort was
made to preserve the sense of the comments made and
to convey the information presented without either an
exhaustive or a literal recording of all comments.
Although not listed as a discussant in the program,
Pocock was called on to present a quantitative overview
he had prepared ofthe effect measures derived from the
different epidemiologic studies presented. The key
elements of Pocock's overview analysis and his inter-
pretation of them were incorporated into his manu-
script, which has been included in these proceedings.
In his summarization remarks presented during the
overview discussion, Pocock suggested that the point
estimate of the regression coefficient of blood pressure
associated with blood lead and the confidence interval
around that estimate for each study indicated overlap
among the various general population epidemiologic
studies, with evidence of compatibility of estimates. It
was his opinion that a zero increase in systolic blood
pressure with a doubling of blood lead was not
compatible with the overall data, nor was an increase of
3 mm Hg in systolic blood pressure compatible. His
impression was that a doubling of blood lead seemed
associated with an increase of about 1 mm Hg in
systolic blood pressure. Further, he felt that the under-
standing of and the control of confounding factors
were quite different among studies and incomplete in
some. He cited the example of alcohol and suggested
that other confounding factors remained to be
discovered and, obviously, adjustments for uniden-
tified factors can not have taken place in the obser-
vational studies reported to date. Although the
overview was consistent with an association between
blood lead and blood pressure, it was his impression
that it was small in magnitude, weak in strength, and
that the overall evidence did not permit an inference
regarding a causal relationship between blood lead and
blood pressure values. Following Pocock's remarks, the
session heard from the planned panel discussants.
Smith stated that he would play the role of devil's
advocate and, despite his being impressed by the
amount and quality of work reported, that his
comments generally would be of a critical nature. In
particular, he pointed out that the quantitative over-
view, which suggested a general trend of positive
coefficients ofthe relationship ofblood pressure to blood
lead levels, was fraught with difficulties. The models
used among the studies were for the most part
different. The number and type of covariants included
were not the same among the models used and the
mathematical treatment of the variables included
across models often varied; for example, the square of
age was used in some studies and not in others. He
suggested that although the use of these covariants
might not make much difference in terms of the
estimator, it could make a major difference in terms of
confidence intervals.
Smith called attention to the point of the impli-
cations of a policy decision to eliminate lead from gas-
oline focusing on new health outcomes based on
alternative products. He emphasized the importance of
this in the case of the relatively small effect associated
with lead which the overview analysis had indicated.
Smith pointed out some fundamental differences
between the research designs used in experimental
biologic research and the multivariate type measure-
ments and analyses performed in the epidemiologic
studies. He focused particularly on the need for more
detailed analysis of the relationship of blood lead to
blood pressure across the multiple NHANES study sites
and inquired about the consistency of a positive
association when this was done. He also raised the
point of differences in the blood lead-blood pressure
relationship among demographic subgroups, with the
possibility of a negative association for women.
Goyer presented an overview of a general nature
regarding what he regarded as the two major objectives
of experimental work: one was to confirm human
observations and another to define mechanisms and
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provide understanding for intervention and preven-
tion programs. He stated that he believed that the
experimental studies of Vander indicated that expo-
sure of experimental animals to lead can produce
changes in blood pressure and that the epidemiologic
work shows the same; however, beyond that, it was his
impression that the animal work becomes confusing.
This may derive from the fact that the animal work
has focused on different situations from that which
produces elevations in blood pressure with lead expo-
sure in the human situation. He reminded the
audience that the main focus of the conference was on
the relatively minor increases in blood pressure in the
general population in relation to general blood lead
levels and there were few experimental models that
have addressed this. The majority of animal experi-
ments in the older literature are probably not relevant
to the understanding of this phenomenon as they are
probably due to different mechanisms. The first
experiments that begin to relate to epidemiologic
observations are those of Vander and Victery, Perry
and Erlanger.
Goyer noted that Vander's model showed relatively
small increases in blood pressure at relatively low levels
of lead exposure and that these effects could not be
produced at higher blood lead levels in a manner that
seemed analogous to that observed in the general pop-
ulation. He noted that the blood lead levels achieved
appeared to be similar despite markedly higher expo-
sure levels and raised the question of the inability of
the rat to modify its blood lead in response to high
levels of lead exposure and that the blood lead levels
may not validly reflect tissue levels, a question which
came up in other contexts and raised the question of
measuring lead in human tissues other than that of
blood, despite its obvious difficulties.
Goyer identified as one of the major research needs
the development of animal models that resulted in
predictable changes in blood lead and blood pressure on
fixed exposure. Essential to doing this would be a better
definition of diet, the genetics of the animal and the
environment. Ideally, studies should provide more
longitudinal information. Much more information
is required about calcium and lead interactions, the
mechanisms of which require further explanation.
Johns then reviewed the evidence presented for
mechanisms by which lead could increase blood
pressure. Those mentioned included:
a) Alteration in intracellular calcium in all forms of
hypertension is assumed, but the level of intracellular
free calcium ion is of importance and these concentra-
tions have not been measured, just assumed.
b) Noncalcium mechanisms: With prolonged
muscle contraction, the intracellular calcium concen-
tration returns to normal; C kinase, a calcium-de-
pendent enzyme affected by lead, can promote smooth
muscle contractions which are not calcium-dependent.
c) A prime target for lead is the endothelial cell of the
blood vesselwall; these cells contribute to the conversion
of angiotensin I to angiotensin II (AII) and since the
level ofAll in some ofthe Vander reports is observed to
be low, it may be a result of direct action of lead on the
endothelial cell. These cells also produce endothelium-
derived relaxing factor (EDRF), which is responsible
for basal tone in blood vessels, and if the endothelial
cells are destroyed by lead, this could cause a
contraction in the smooth muscle. An increase in blood
calcium level would tend to increase the relaxation of
the blood vessel due to noncontrolled leak of ionized
calcium into the endothelial cells.
d) Lead could alter calcium entry or calcium cycling
across the membrane or the release of calcium from
sarcoplasmic reticulum, any of which can affect
contractile systems. It appears from the in vitro studies
of Webb that the increased reactivity of isolated vessels
to agonists may be due to increased sarcoplasmic
reticulum calcium content.
The plasma membrane of vascular smooth muscle
has a number of cation channels and pumps. It is not
unusual for a compound to promote calcium entry at
low concentrations and block calcium entry at high
concentrations. Therefore, it did not surprise him that
lead at different levels appears to have opposite effects on
blood pressure. Possibly at low lead levels, the endo-
thelium is destroyed while at high lead levels, it can
also act as a calcium channel blocker. The potassium
channel may also be affected, leading in some cases to
membrane depolarization and calcium entry via
voltage sensitive channels. Levels of lead required to
inhibit sodium-potassium ATPase seem to be quite
high, perhaps of pharmacologic significance only.
Lead could also affect sodium-calcium exchange which
may not directly affect contractility but alter the filling
or emptying of the sarcoplasmic reticulum after
contraction.
Johns wrapped up his remarks by indicating that
since all ion channels could be affected in smooth
muscle membranes, and if there is endothelial cell
involvement as well-there will be a need to find out
which of these pathways are affected by lead through
continued basic research. If a 2 to 3 mm Hg rise in
human blood pressure attributable to lead exposure is
considered important, then it would be interesting to
follow up these research needs.
Dustan continued with a discussion of the animal
experimental model which, in the instance of lead
exposure, she thought could be an excellent model of
mild hypertension in man. Most of the experimental
models we have of hypertension had been associated
with rather severe hypertension and with conse-
quences of severe hypertension in terms of arterial
damage, whereas what we need is something more of
replication of what we see in man, where much of
hypertension is mild. Further, this model offers the
opportunity to see the relationship of mild blood
pressure to atherosclerosis in the animal model.
Dustan commented on the confusing observations
in clinical studies of the apparent lack of relationship
between hypertension and kidney damage with lead.
Despite the methodologic limitations and defects in the
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data available, she was impressed with the striking
finding that people who have died of lead nephropathy
or have died of renal failure have not had secondary
hypertension. For future research, she called for
detailed analysis of the black examinees in the
NHANES sample, noting the somewhat higher blood
lead levels and well-known excess of hypertension in
blacks. In these analyses, studies of serum creatinine
might provide insight into whether or not hyper-
tension in the black is kidney-related in either of two
ways: one, the kidney as a victim of elevated pressure,
and the other, the kidney as the culprit.
Kannel presented a synthesis of the studies and a
community perspective. He reviewed the rules of
evidence in determining whether an observed
association reflects a causal relationship. He noted
consistency of results with a similarity of trends
among population surveys, although in some
instances the results were not statistically significant
and other times when risk factors other than lead were
not taken into account. He called for prospective studies
on the predictive value of lead for subsequent
hypertension and the need to study its effect on age
trends in blood pressure over time. The strength of the
blood lead-blood pressure relationship is rather weak
and does not fulfill the usual criterion for causality.
The weak association does not lead to a clear dose-
response relationship and the shape of the dose-
response curve is not known with certainty. There
seems to be some loss ofeffect at higher ortoxic doses of
lead. If the relationship does hold at ambient levels of
lead, this is of great public health importance owing to
the large attributable risk and the modifiable nature of
lead as a potential risk factor for hypertension.
Although the effect seems to be independent, more data
are needed concerning the associated cadmium and
calcium intake and exploration for possible
interactions should be carried out. The final criterion,
biologic plausibility, is partially met. Although a
number of possible mechanisms have been postulated,
it is not clear from the evidence reviewed which are
operative. In summary, Kannel suggested that the
available information suggested a possible, but by no
means certain, causal relationship; however, the public
health implications are large in view of the current
ubiquitous exposure, the effects oflow-lead exposure on
blood pressure, and the possibility of modification.
Kannel felt that in terms of population research,
there was a need for ongoing prospective studies to
include blood lead in their next round of exams and
then study prospectively the relationship to the trends
in blood pressure over time. There will also be the
opportunity to take advantage of areas with declining
lead exposure and measure blood pressure before,
during, and after change. Two particular deficiencies
in the data available as identified by Kannel were those
regarding information on the association in women,
where the effect seems to be less pronounced than for
men, and the need for more information on the
contribution of blood lead differences to the well-known
black/white differences in blood pressure.
In opening the general discussion, there were
comments from Goyer, Smith, and Vander regarding
the interpretation of epidemiologic findings compared
with those derived from experimental work. Smith
emphasized the point that the independent effect of one
factor was not what was relevant to the human
circumstance, but rather the potential for interaction of
lead with other factors. This was agreed to by the
experimentalists who had demonstrated positive
interactive effects with cadmium and negative
interactive effects with calcium. Schwartz elaborated
on the point and suggested that this might explain
why in Perry's experiments elevation in blood pres-
sure was seen at lower doses of lead in contrast to
Vander's experiments; one possibility is Perry may
have had less calcium in the diet of his rats than was
present in the experiments performed by Vander.
Pocock indicated that he had blood cadmium mea-
sures on 7000 of the men in his studies and that
cadmium did not seem related to blood pressure; how-
ever, he added he had not yet tested for interaction
effects. Further, he pointed out that cigarette smoking
is a major source of cadmium and that if cadmium
were affecting blood pressure, one would expect a
positive blood pressure smoking relationship which
was not observed in his study. de Kort added that he
too observed the absence of an association between
cadmium and blood pressure in a small study of lead
workers in the Netherlands.
Kannel emphasized the desirability of performing
animal experiments which have relevance to hyper-
tension in humans, and this led to discussion of the
desirability of study of exposures early in life. Vander
advanced the idea of beginning animal experiments of
this type based on lead exposure in utero. Wedeen
returned to the question of the absence of hypertension
in association with lead exposure in the presence of
renal disease. He suspected that this follows from the
epidemiologic ascertainment of the general population
with normal pressure and blood-lead levels, and
exclusion of diseased persons. He advanced the hy-
pothesis that the massive overrepresentation of black
males in dialysis units could be related to lead exposure
in childhood combined with lower calcium intakes
and the association with alcohol.
Webb returned to the association of calcium with
hypertension and pointed out that the evidence sug-
gested that the problem was not so much one of con-
centration but regulation of the way calcium moves
(flux) or activates contractile responses. He suggested
that studies should be directed to regulation in terms
of calcium interactions with lead.
In response to a question that returned to the issue of
the association of blood lead and blood pressure in
blacks, Schwartz indicated that in some of his analyses,
blood lead explains some of the black excess in high
blood pressure, but not all of it. Schwartz returned to
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the question raised by Smith regarding the issue of
what replaced lead when it was to be removed from
gasoline and he cited cost benefit analyses prepared for
regulatory hearings. The possibility of some increase
in emission of carcinogens, secondary to increases in
the aromatic content and branching paraffins of
gasoline, were estimated to result in markedly lower
effects on health than those putatively associated with
lead. J. Cole (ILZRO) asked the panel to discuss a com-
ment that Schwartz made that a 1 mm Hg rise in blood
pressure could be associated with a 1% increase in
ischemic heart disease. Pocock stated that a 1% heart
disease rate change was roughly that estimated to be
associated with a 1 mm Hg change in blood pressure;
however, he argued that it was necessary to recognize
two links in the chain of the argument, the lead blood
pressure link and the blood pressure ischemic heart
disease link. He suggested that the blood pressure
ischemic heart disease link relates to the long-term
pattern of blood pressure and its association with the
risk of ischemic heart disease in late middle age,
whereas the lead blood pressure association may be ofa
much more short-term nature and whether or not it
reflects a chronic association is unknown. Tyroler and
Kannel each advanced the idea that the human
experimental data, i.e., the clinical trials evidence,
clearly showed that lowering blood pressure decreases
direct pressure related phenomena such as renal,
cerebral, and congestive heart failure sequelae; how-
ever, clear evidence of efficacy of blood pressure
reduction in prevention of atherosclerotic complica-
tions, such as ischemic heart disease, was not available.
Mahaffey raised the question of the body burden of
lead and asked what recommendations would be made
to this end. Wedeen suggested that the measurement of
bone stores oflead by in vivo X-ray fluorescence was an
approach. Grandjean stated that his group has
developed a method of analyzing lead in teeth using
the lead level in circumpulpal dentine. There was some
debate as to whether pulpal dentine or X-ray fluo-
rescence was a more valid index of lead accumulated
over a lifetime. Vander repeated a suggestion he had
made regarding the possibility of estimating ultra-
filtrable lead in plasma. Although theoretically ideal,
he emphasized that it had been impossible in the past
because of contamination, but that rigorous meth-
odologic techniques, including absolutely ultraclean
laboratory settings for determination, would make
this feasible. He suggested also that isotopic equili-
bration of plasma with an isotope of lead, followed by
ultrafiltration, might provide a technique applicable to
large surveys. Grandjean pointed out that an addi-
tional reason for not using plasma lead other than the
difficulty of its measurement is its marked variability
with time and Bernard indicated that the half-life of
plasma lead is only hours to perhaps a few days.
S. Snedeker (NIEHS) expanded upon the implica-
tions of dealing with interactive effects of minerals.
She pointed out that this covers different levels of
research: the effect of calcium and other minerals on
lead bioavailability and the lead body burden. These
might be substantially different than the interactive
effects of lead and calcium on tissue levels, such as
vascular tissue or the kidney. Snedeker also pointed out
that there are some subgroups that have not been dis-
cussed at length, in particular, women at the meno-
pause. The release ofcalcium and the effects ofhormone
treatment were worthy of investigation since some
preliminary data indicated a slightly higher blood
lead-blood pressure slope in the 40- to 55-year age range
with subsequent leveling off. Schwartz indicated that
his group has a paper in manuscript suggesting that
blood lead levels increase immediately after menopause
and that a statistical interaction term for age suggests
that they then decline and that this is similar to the
pattern of calcium release after menopause following
calcium mobilization from bone.
A presentation and review of the design and plans
for the National Health and Nutrition Examination
Survey (NHANES) III were considered and served as a
basis for discussion regarding studies that could be
added to this survey to further elucidate the blood lead-
blood pressure relationship.
S. Haynes (NCHS) described the plans for NHANES
III. She indicated that with a sample size of 16,000 it
would be larger than the previous two surveys. The
plan is to start the survey in 1988 and to complete it by
1994; however, estimates from the field will be available
by 1991 for blacks and whites and at the end of the 6
years for Mexican Americans and Puerto Ricans.
Planning is moving forward to do a mortality follow-
up of the population using the national death index.
There also are plans to have a reexamination or
reinterview of the NHANES III population, probably in
1996. Among the elements of the examination, she
mentioned a special kidney exam which will be more
extensive than others previously done in the NHANES
surveys to follow up persons at risk of kidney disease
with special reexaminations for glomerular filtration
rate in clinical centers. Wedeen pointed out that infor-
mation could be derived from detailed analysis of
serum creatinine and Haynes indicated that a manu-
script was in preparation based on analyses of the
serum creatinine values of NHANES II and that
additional studies of their relationships to blood lead
would be feasible by secondary analysis of these extant
data.
Haynes added that a home examination is to be
added to the mobile unit survey. In this home survey,
limited examinations will include blood pressures so
that it will be possible to have home blood pressures
measures as well as clinic measures for the entire
population. This will permit better definitions of
hypertension. In response to a question by Smith,
Haynes pointed out that detailed plans for analysis
have been developed in advance to identify the basic
questions that need to be addressed following comple-
tion of this survey. Haynes also indicated that there is
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a new philosophy at the National Center for Health
Statistics in disseminating results. The first target is
early publication in medical journals and following
that, publication of the material in Center reports. In
summary of the overall scope of the exam, excluding
the environmental components, Haynes indicated that
there will be an electrocardiogram, kidney exam, oral
glucose tolerance test, hearing exam, visual and dental
exams, a 24-hr diet recall, and a series of neurologic
tests, measurement of height, weight, anthropometrics,
body impedance, and bone densitometry to determine
osteoporosis.
G. Provenzano (U.S. EPA) summarized the EPA
plans for measurement of environmental aspects
within NHANES III. The exposure measurements will
be based on estimation of exposure primarily in the
home. These were ascertained by expanding the
household interview to provide information on
factors that affect indoor air quality, such as types of
heating equipment, cooking equipment, size of indoor
spaces, number of rooms, etc. The questionnaire
information was to be supplemented by some indoor
air monitoring, e.g., radon measurement. Tap water is
to be analyzed for toxic and essential metals. In
addition to environmental measurements, measure-
ments of individuals are to be performed both to assess
exposure and for effects estimation. Among the effects
measurement, in addition to blood pressure, there will
be a neurobehavioral test battery. The body measure-
ments will include those determined from serum,
whole blood, and urine and include a larger number
of toxic metals and essential metals that were not
measured in NHANES II. The final list of metals to be
analyzed in addition to lead has not been determined,
but will include cadmium, and most probably serum
selenium, manganese, and aluminum, and urinary
arsenic. Serum cotinine will be assessed to provide
sensitive and objective evidence of exposure to tobacco
smoke. Provenzano concluded with the posing of three
types of questions relevant to the blood lead-blood
pressure question. First, what laboratory analysis
protocol should be used for measuring lead in blood in
the NHANES III? Do we need increased sensitivity in
view of the anticipated markedly lower blood lead levels
in the early 1990s? Will we be able to detect low levels
with appropriate precision and accuracy? Will it be
possible to detect the shape ofthe dose response function
at very low blood lead levels? Second, which covariates
should be included in NHANES III? Despite the very
long list available and analyzed in NHANES II, what
other potential confounders were missing from
NHANES II and should be added to the NHANES III?
Finally, what are the recommendations for the tech-
niques for blood pressure measurement in NHANES
III.
Schwartz reinforced Provenzano's comments
regarding the anticipated much lower levels of blood
lead in NHANES III and emphasized the need for more
accurate and precise measurements ofblood lead levels.
Schwartz questioned whether there were going to be
home dust samples analyzed for routes of exposure to
metals other than drinking water. Provenzano
indicated that the difficulties in sampling for metals
made it unlikely that this would be attempted.
Mahaffey emphasized the need to develop indices of
integrated exposure to lead. Wedeen suggested that the
estimation of bone density might provide techniques
close to those used to measure bone lead. V. Bonar
pointed out that there is considerable evidence that
social variables are related both to blood pressure and
blood lead and inquired regarding the measures of
potential, social confounders in NHANES III. Lilis
emphasized the importance of estimation of alcohol
and smoking and added that these two plus water were
major sources oflead exposure.
Cole pointed out the limitations in the observational
epidemiologic data available in the past and urged a
systematic planned approach to NHANES III to
contribute to the question of whether or not any
observed association was causal.
Tyroler noted that the morning's session began
with an overview by Pocock and asked Schwartz if he
would conclude the session with his perspective on the
overview of the blood pressure-blood lead relationship.
Schwartz indicated that he generally agreed with
Pocock's summarization, that is, that there is a broad
consistency in the results across studies, that the
coefficient relating blood lead to blood pressure on the
log scale indicated that doubling of blood lead was
associated with a 1 to 2 mm change in mercury. Thus,
based on the epidemiologic data, he concluded that
there is an association, it is not large in respect of the
millimeters mercury explained, and the studies are
consistently positively around that range. He
disagreed with Pocock regarding the causal inter-
pretation and suggested that although causal infer-
ences could not readily be drawn from the epide-
miologic data per se, that they were consistent with the
animal data and that for the animal data it was not
difficult to draw a causal inference. Information was
emerging within the animal studies regarding
mechanisms such as exaggerated alpha adrenergic
responses, and disturbance of calcium metabolism and
that similar mechanisms have been postulated for
mild hypertension in humans. Based on these obser-
vations, Schwartz concluded that there is probably,
although not definitively established, a causal rela-
tionship. Schwartz emphasized that lead is a control-
lable element in the environment and that removal of
exposure early in life could prevent the emergence of
elevated blood pressure, an approach much safer than
that of treating elevated blood pressure after it had
emerged.
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